Renalytix Ai Stock Alpha and Beta Analysis

RNLX Stock  USD 0.15  0.01  6.25%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Renalytix AI. It also helps investors analyze the systematic and unsystematic risks associated with investing in Renalytix over a specified time horizon. Remember, high Renalytix's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Renalytix's market risk premium analysis include:
Beta
(0.08)
Alpha
(0.87)
Risk
6.53
Sharpe Ratio
(0.16)
Expected Return
(1.05)
Please note that although Renalytix alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Renalytix did 0.87  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Renalytix AI stock's relative risk over its benchmark. Renalytix AI has a beta of 0.08  . As returns on the market increase, returns on owning Renalytix are expected to decrease at a much lower rate. During the bear market, Renalytix is likely to outperform the market. Book Value Per Share is likely to rise to -0.07 in 2024. Tangible Book Value Per Share is likely to rise to -0.07 in 2024.

Enterprise Value

29.45 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Renalytix Backtesting, Renalytix Valuation, Renalytix Correlation, Renalytix Hype Analysis, Renalytix Volatility, Renalytix History and analyze Renalytix Performance.

Renalytix Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Renalytix market risk premium is the additional return an investor will receive from holding Renalytix long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Renalytix. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Renalytix's performance over market.
α-0.87   β-0.08

Renalytix expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Renalytix's Buy-and-hold return. Our buy-and-hold chart shows how Renalytix performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Renalytix Market Price Analysis

Market price analysis indicators help investors to evaluate how Renalytix stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Renalytix shares will generate the highest return on investment. By understating and applying Renalytix stock market price indicators, traders can identify Renalytix position entry and exit signals to maximize returns.

Renalytix Return and Market Media

The median price of Renalytix for the period between Sat, Aug 24, 2024 and Fri, Nov 22, 2024 is 0.19 with a coefficient of variation of 31.91. The daily time series for the period is distributed with a sample standard deviation of 0.07, arithmetic mean of 0.22, and mean deviation of 0.07. The Stock received some media coverage during the period.
 Price Growth (%)  
       Timeline  
1
Renalytix AI Eyes Growth with 10M Fundraise and Restructuring - TipRanks
09/30/2024
2
Acquisition by Icahn School Of Medicine At Mount Sinai of 13366750 shares of Renalytix at 0.116 subject to Rule 16b-3
11/01/2024
3
Renalytix plc Reports Financial Results for First Quarter of Fis - GuruFocus.com
11/20/2024

About Renalytix Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Renalytix or other stocks. Alpha measures the amount that position in Renalytix AI has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2022 2023 2024 (projected)
Payables Turnover0.830.920.820.42
Days Of Inventory On Hand206.3496.99111.54105.96

Renalytix Upcoming Company Events

As portrayed in its financial statements, the presentation of Renalytix's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Renalytix's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Renalytix's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Renalytix. Please utilize our Beneish M Score to check the likelihood of Renalytix's management manipulating its earnings.
4th of April 2024
Upcoming Quarterly Report
View
14th of June 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
26th of September 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
30th of June 2023
Last Financial Announcement
View

Build Portfolio with Renalytix

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Renalytix Stock Analysis

When running Renalytix's price analysis, check to measure Renalytix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Renalytix is operating at the current time. Most of Renalytix's value examination focuses on studying past and present price action to predict the probability of Renalytix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Renalytix's price. Additionally, you may evaluate how the addition of Renalytix to your portfolios can decrease your overall portfolio volatility.